Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Genetic Analysis of Immune Disorders

View source ↗

Summary

This Clinical Trial Update notes that an NIAID study is recruiting to analyze genetic immune disorders linked to STAT1, GATA2, and STAT3 pathways.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: DOK 8, STAT1 | Status: RECRUITING